Tiger Eye Capital LLC Guardant Health, Inc. Transaction History

Tiger Eye Capital LLC

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$59.49 - $82.78 $2.56 Million - $3.56 Million
-42,955 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$62.59 - $110.3 $2.03 Million - $3.58 Million
-32,490 Reduced 43.06%
42,955 $2.74 Million
Q2 2019

Aug 14, 2019
BUY
$63.94 - $91.11 $3.19 Million - $4.55 Million
49,945 Added 195.86%
75,445 $6.51 Million
Q1 2019

May 15, 2019
BUY
$34.3 - $97.98 $874,649 - $2.5 Million
25,500 New
25,500 $1.96 Million

Others Institutions Holding GH

# of Institutions
330
Shares Held
113M
Call Options Held
680K
Put Options Held
1.66M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $2.35B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Tiger Eye Capital LLC Portfolio

Follow Tiger Eye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tiger Eye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tiger Eye Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email